Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13030 | 864 | 34.6 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
3458 | 2 | MASPIN//TAFI//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | 1506 |
13030 | 1 | TAFI//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR//CARBOXYPEPTIDASE U | 864 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TAFI | authKW | 3890247 | 16% | 80% | 138 |
2 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | authKW | 1901973 | 10% | 65% | 83 |
3 | CARBOXYPEPTIDASE U | authKW | 1202553 | 4% | 97% | 35 |
4 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI | authKW | 644648 | 3% | 79% | 23 |
5 | PROCARBOXYPEPTIDASE U | authKW | 388744 | 1% | 100% | 11 |
6 | METALLOCARBOXYPEPTIDASE | authKW | 378260 | 2% | 63% | 17 |
7 | FIBRINOLYSIS | authKW | 302335 | 21% | 5% | 180 |
8 | CARBOXYPEPTIDASE R | authKW | 282723 | 1% | 100% | 8 |
9 | CARBOXYPEPTIDASE T | authKW | 282723 | 1% | 100% | 8 |
10 | CARBOXYPEPTIDASE | authKW | 263649 | 6% | 15% | 50 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 8896 | 31% | 0% | 269 |
2 | Peripheral Vascular Diseases | 5280 | 23% | 0% | 201 |
3 | Biochemistry & Molecular Biology | 1580 | 37% | 0% | 322 |
4 | Medical Laboratory Technology | 282 | 3% | 0% | 28 |
5 | Biophysics | 220 | 7% | 0% | 59 |
6 | Biochemical Research Methods | 44 | 3% | 0% | 29 |
7 | Immunology | 40 | 5% | 0% | 45 |
8 | Cell Biology | 30 | 5% | 0% | 45 |
9 | Chemistry, Medicinal | 30 | 3% | 0% | 22 |
10 | Medicine, Research & Experimental | 25 | 3% | 0% | 28 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SECT GEN EXPT PATHOL | 168378 | 1% | 53% | 9 |
2 | BIOL FONAMENTAL | 109950 | 2% | 16% | 19 |
3 | MOL CELLULAR PATHOPHYSIOL | 94230 | 1% | 33% | 8 |
4 | THER EUT DIAGNOST ANTIBODIES | 87252 | 1% | 22% | 11 |
5 | CLIN CHEM L25 | 79514 | 0% | 75% | 3 |
6 | UNITAT CIENCIES | 66953 | 1% | 32% | 6 |
7 | HAEMATOL G03 647 | 51964 | 1% | 29% | 5 |
8 | EXPT VASC MED | 49223 | 2% | 7% | 19 |
9 | BIOTECNOL BIOMED | 49103 | 3% | 5% | 30 |
10 | CNRS UP A 6033 | 47119 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 40557 | 8% | 2% | 67 |
2 | THROMBOSIS AND HAEMOSTASIS | 12304 | 7% | 1% | 59 |
3 | THROMBOSIS RESEARCH | 5208 | 5% | 0% | 39 |
4 | BLOOD COAGULATION & FIBRINOLYSIS | 3086 | 2% | 1% | 17 |
5 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1219 | 9% | 0% | 75 |
6 | MICROBIOLOGY AND IMMUNOLOGY | 1101 | 1% | 0% | 12 |
7 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 1050 | 1% | 0% | 7 |
8 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 875 | 0% | 1% | 3 |
9 | CLINICA CHIMICA ACTA | 697 | 2% | 0% | 15 |
10 | BRITISH JOURNAL OF HAEMATOLOGY | 645 | 2% | 0% | 16 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TAFI | 3890247 | 16% | 80% | 138 | Search TAFI | Search TAFI |
2 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR | 1901973 | 10% | 65% | 83 | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR |
3 | CARBOXYPEPTIDASE U | 1202553 | 4% | 97% | 35 | Search CARBOXYPEPTIDASE+U | Search CARBOXYPEPTIDASE+U |
4 | THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI | 644648 | 3% | 79% | 23 | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI | Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI |
5 | PROCARBOXYPEPTIDASE U | 388744 | 1% | 100% | 11 | Search PROCARBOXYPEPTIDASE+U | Search PROCARBOXYPEPTIDASE+U |
6 | METALLOCARBOXYPEPTIDASE | 378260 | 2% | 63% | 17 | Search METALLOCARBOXYPEPTIDASE | Search METALLOCARBOXYPEPTIDASE |
7 | FIBRINOLYSIS | 302335 | 21% | 5% | 180 | Search FIBRINOLYSIS | Search FIBRINOLYSIS |
8 | CARBOXYPEPTIDASE R | 282723 | 1% | 100% | 8 | Search CARBOXYPEPTIDASE+R | Search CARBOXYPEPTIDASE+R |
9 | CARBOXYPEPTIDASE T | 282723 | 1% | 100% | 8 | Search CARBOXYPEPTIDASE+T | Search CARBOXYPEPTIDASE+T |
10 | CARBOXYPEPTIDASE | 263649 | 6% | 15% | 50 | Search CARBOXYPEPTIDASE | Search CARBOXYPEPTIDASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HEYLEN, E , WILLEMSE, J , HENDRIKS, D , (2011) AN UPDATE ON THE ROLE OF CARBOXYPEPTIDASE U (TAFIA) IN FIBRINOLYSIS.FRONTIERS IN BIOSCIENCE-LANDMARK. VOL. 16. ISSUE . P. 2427 -2450 | 155 | 80% | 7 |
2 | FOLEY, JH , KIM, PY , MUTCH, NJ , GILS, A , (2013) INSIGHTS INTO THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR FUNCTION AND REGULATION.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 11. ISSUE . P. 306-315 | 90 | 88% | 20 |
3 | MARX, PF , VERKLEIJ, CJN , SERON, MV , MEIJERS, JCM , (2009) RECENT DEVELOPMENTS IN THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR RESEARCH.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 9. ISSUE 10. P. 1165-1173 | 100 | 96% | 7 |
4 | VERCAUTEREN, E , GILS, A , DECLERCK, PJ , (2013) THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR: A PUTATIVE TARGET TO ENHANCE FIBRINOLYSIS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 39. ISSUE 4. P. 365 -372 | 86 | 97% | 10 |
5 | LEURS, J , HENDRIKS, D , (2005) CARBOXYPEPTIDASE U (TAFLA): A METALLOCARBOXYPEPTIDASE WITH A DISTINCT ROLE IN HAEMOSTASIS AND A POSSIBLE RISK FACTOR FOR THROMBOTIC DISEASE.THROMBOSIS AND HAEMOSTASIS. VOL. 94. ISSUE 3. P. 471-487 | 127 | 74% | 51 |
6 | DECLERCK, PJ , (2011) THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR.HAMOSTASEOLOGIE. VOL. 31. ISSUE 3. P. 165-+ | 86 | 95% | 10 |
7 | BOFFA, MB , KOSCHINSKY, ML , (2007) CURIOUSER AND CURIOUSER: RECENT ADVANCES IN MEASUREMENT OF THROMBIN-ACTIVATABLE FIBIRINOLYSIS INHIBITOR (TAFI) AND IN UNDERSTANDING ITS MOLECULAR GENETICS, GENE REGULATION, AND BIOLOGICAL ROLES.CLINICAL BIOCHEMISTRY. VOL. 40. ISSUE 7. P. 431-442 | 96 | 87% | 51 |
8 | PLUG, T , MEIJERS, JCM , (2016) STRUCTURE-FUNCTION RELATIONSHIPS IN THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 14. ISSUE 4. P. 633 -644 | 62 | 82% | 4 |
9 | MARX, PF , (2004) THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR.CURRENT MEDICINAL CHEMISTRY. VOL. 11. ISSUE 17. P. 2335-2348 | 97 | 84% | 29 |
10 | WILLEMSE, JL , HEYLEN, E , NESHEIM, ME , HENDRIKS, DF , (2009) CARBOXYPEPTIDASE U (TAFIA): A NEW DRUG TARGET FOR FIBRINOLYTIC THERAPY?.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 7. ISSUE 12. P. 1962 -1971 | 70 | 89% | 24 |
Classes with closest relation at Level 1 |